Filing Details
- Accession Number:
- 0001773751-24-000160
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-05 18:46:10
- Reporting Period:
- 2024-06-03
- Accepted Time:
- 2024-06-05 18:46:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1773751 | Hims & Hers Health Inc. | HIMS | Services-Offices & Clinics Of Doctors Of Medicine (8011) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1837815 | Melissa Baird | 2269 Chestnut Street, #523 San Francisco CA 94123 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2024-06-03 | 70,506 | $0.40 | 611,938 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2024-06-03 | 64,406 | $20.32 | 547,532 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2024-06-03 | 6,100 | $20.86 | 541,432 | No | 4 | S | Direct | |
| Class A Common Stock | Acquisiton | 2024-06-04 | 17,625 | $0.40 | 559,057 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2024-06-04 | 9,293 | $20.69 | 549,764 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2024-06-04 | 8,332 | $20.11 | 541,432 | No | 4 | S | Direct | |
| Class A Common Stock | Acquisiton | 2024-06-05 | 17,625 | $0.40 | 559,057 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2024-06-05 | 14,063 | $21.25 | 544,994 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2024-06-05 | 3,562 | $21.66 | 541,432 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2024-06-03 | 70,506 | $0.00 | 70,506 | $0.40 |
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2024-06-04 | 17,625 | $0.00 | 17,625 | $0.40 |
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2024-06-05 | 17,625 | $0.00 | 17,625 | $0.40 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 634,402 | 2028-03-28 | No | 4 | M | Direct | |
| 616,777 | 2028-03-28 | No | 4 | M | Direct | |
| 599,152 | 2028-03-28 | No | 4 | M | Direct |
Footnotes
- The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.
- Includes 2,500 shares acquired on May 20, 2024, under the Hims & Hers Health, Inc. 2020 Employee Stock Purchase Plan.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.715 - $20.68. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.70 - $21.14. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.495 - $20.855. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.50 - $20.49. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.60 - $21.59. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.595 - $21.715. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.
Billionaire Hedge Funds
